[Webinar] Alternative Funding Models for High-Cost Innovative Drugs - Thailand & APAC

Alt funding models for high cost innovative drugs - updated webinar banner 230711
Chulabhorn Royal Academy, Ipsos in Singapore, and Roche recognized the importance of treating cancer patients or those with rare diseases that there have been significant rapid advancements in technology, research, and the development of groundbreaking medications approved by regulatory bodies such as the Food and Drug Administration, both in Thailand and internationally. However, within the context of Thailand's healthcare system, there are still limitations that hinder timely access to these aforementioned medications, leaving patients with difficulties in receiving the necessary treatment.

In light of this, Chulabhorn Royal Academy, Ipsos in Singapore and Roche collaborated to organize a virtual webinar entitled "Alternative Funding Models for High-Cost Innovative Drugs – Thailand & APAC." The objective of this webinar is to disseminate knowledge about research efforts focused on developing policy proposals for new alternative financing mechanisms that enhance patients’ access to innovative medications. Additionally, the event aims to facilitate the exchange of Thailand and APAC experiences and opinions regarding the International Medicine Fund (IMF) or Managed Entry Agreement (MEA) systems implemented by governments in the Asia-Pacific region e.g. Korea, and particularly in the future of Thailand and SEA roadmap.

Register to attend the webinar

Webinar Agenda




1.30pm (BKK)
2.30pm (SGT)

Opening Remarks

Associate Professor Chusak Limsakul, PhD
Acting Deputy Secretary General
Chulabhorn Royal Academy

1.35pm (BKK)
2.35pm (SGT)

Overview of White Papers and Workshop

Dr Jomtana Siripaibun, MD
Director, Oncology Medical Center
Chulabhorn Hospital

1.40pm (BKK)
2.40pm (SGT)

Alternative Financing Solutions for Thailand - 
An Overview and Best Practices

- Establishing viable options for Thailand

- Leveraging examples in the region

- Value of MEAs for Thailand

- Policy impact of Thai MEA in the region

Adrien Gras
APAC Head of Market Access & HEOR, 
Ipsos in Singapore
1.55pm (BKK)
2.55pm (SGT)

Panel Discussion:
The Future of Alternative Funding Models in Thailand and APAC

- Understanding the South Korean MEA experience

- Potential value and challenges of MEA implementation for Thailand reimbursement system

- Evolution of MEA adoption in APAC

Professor Jeonghoon Ahn
Ewha Womans University, South Korea

Dr Chanin Limwongse, MD
Faculty of Medicine, Siriraj Hospital

Moderated by:
Adrien Gras
APAC Head of Market Access & HEOR,
Ipsos in Singapore

2.25pm (BKK)
3.25pm (SGT)
Closing Remarks

Assistant Professor Dr Teerapat Ungtrakul, MD
Acting Dean, Princess Srisavangavadhana
College of Medicine
Chulabhorn Royal Academy


market access webinar presenters july 2023

Further reading: